Skip to content
StockMarketAgent
Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

LON/0A3S stock hub

LON/0A3S has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

LON/0A3Sis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
1.2B
London Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
LON/0A3S
In the news

Latest news · LON/0A3S

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROEn/a
P25 n/aP50 n/aP75 n/a
ROIC15.3
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All LON/0A3S market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
173
Groups with data
11
Currency
USD
Showing 173 of 173 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
United States
Country code
UK
Employees
749
Employees Change
-591%
Employees Change Percent
-38.3
Enterprise value
$856.6M
Exchange
London Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Biological Products, Except Diagnostic Substances
Last refreshed
2026-05-10
Market cap
$1.2B
Price
$10.53
Price currency
USD
Rev Per Employee
602,950.27x
Sic
2836
Symbol
lon/0A3S
Website
https://www.novavax.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

9
MetricValue
Earnings Yield
-5.45%
EV Earnings
-12.88x
EV/EBIT
31.38x
EV/EBITDA
17.15x
EV/FCF
-11.69x
EV/Sales
1.96x
FCF yield
-6.01%
P/B ratio
-11.13x
P/S ratio
2.7x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

14
MetricValue
EBIT Margin
6.24%
EBITDA Margin
9.98%
Gross margin
27.49%
Gross Profit
$124.2M
Gross Profit Growth
-77.38%
Gross Profit Growth Q
-95.3%
Net Income
$-66.5M
Pretax Margin
-14.45%
Profit Margin
-14.73%
Profit Per Employee
$-88,809
ROA
1.99
Roa5y
-13.46
ROCE
5.31
ROIC
15.33

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

7
MetricValue
Cagr1y
73.76%
Cagr3y
10.01%
Cagr5y
-43.14%
Revenue Growth
-52.48x
Revenue Growth Q
-79.07x
Revenue Growth3 Y
-24.01x
Revenue Growth5 Y
-8.3x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Asset Turnover
$0.51
Assets
$790M
Cash
$598.5M
Current Assets
$624.1M
Current Liabilities
$251.2M
Debt
$223.4M
Debt EBITDA
$4.34
Debt FCF
$-3.05
Equity
$-109.6M
Interest Coverage
1.65
Liabilities
$899.6M
Long Term Assets
$165.9M
Long Term Liabilities
$648.4M
Net Cash
$375.1M
Net Cash By Market Cap
$30.74
Net Cash Growth
-1.5%
Net Debt EBITDA
$-8.32
Tangible Book Value
$-195.1M
Tangible Book Value Per Share
$-1.19
WACC
16.84

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
2.48
Inventory Turnover
39.81
Net Working Capital
$-211.9M
Quick ratio
2.38
Working Capital
$385M
Working Capital Turnover
$0.95

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-0.58%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
1Y total return
73.7%
200-day SMA
8.24
3Y total return
33.14%
50-day SMA
9.05
50-day SMA vs 200-day SMA
50over200
5Y total return
-94.06%
All Time High
327.7
All Time High Change
-96.83%
All Time High Date
2021-02-08
All Time Low
3.53
All Time Low Change
194.33%
All Time Low Date
2024-02-05
ATR
0.62
Beta
2.65
Ch YTD
54.61
High
10.73
High52
11.97
High52 Date
2026-02-26
High52ch
-12.03%
Low
9.25
Low52
5.87
Low52 Date
2025-05-12
Low52ch
79.39%
Ma50ch
14.76%
Price vs 200-day SMA
26.09%
RSI
71.32
RSI Monthly
47.34
RSI Weekly
61.17
Sharpe ratio
1.03x
Sortino ratio
1.83
Total Return
-0.58%
Tr YTD
54.61
Tr1m
33.04%
Tr1w
31.02%
Tr3m
28.25%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

3
MetricValue
Operating Income
$28.2M
Operating Income Growth
-91.2
Operating margin
6.24

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
141,464,301%
Net Borrowing
59,098,489.5
Shares Insiders
0.84%
Shares Institutions
57.96%
Shares Qo Q
-1.15%
Shares Yo Y
0.58%
Short Ratio
10.31

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

53
MetricValue
Adjusted FCF
$-98.6M
Average Volume
114,313.3x
Bv Per Share
-0.67
CAPEX
$-4M
Ch1m
33.04
Ch1w
31.02
Ch1y
73.69
Ch3m
28.26
Ch3y
33.14
Ch5y
-94.06
Ch6m
40.05
Change
11.02%
Change From Open
10.61
Close
9.49
Days Gap
0.37
Depreciation Amortization
16,383,035.2
Dollar Volume
4,429,002.2
Earnings Date
2026-05-06
EBIT
$28.2M
EBITDA
$45.1M
EPS
$-0.41
F Score
2
FCF
$-73.3M
FCF EV Yield
-8.56x
Financing CF
54,884,165
Fiscal Year End
December
Founded
1,987
Goodwill
82,804,928.4
Income Tax
$1.2M
Investing CF
-25,225,072
Is Primary Listing
0
Last Earnings Date
2026-05-06
Last Report Date
2026-03-31
Last Split Date
2019-05-10
Last Split Type
Reverse
Ma150
8.28
Ma150ch
25.56%
Ma20
8.47
Ma20ch
22.7%
Net CF
-34,499,029
Open
9.52
Position In Range
86.47
Ppne
46,583,273.6
Price Date
2026-05-08
Price EBITDA
$27.06
Relative Volume
3.68x
Revenue
451,609,749x
SBC By Revenue
5.61x
Share Based Comp
25,334,881
Tax By Revenue
0.28x
Tr6m
40.05%
Volume
420,608
Z Score
-4.23
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does LON/0A3S pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0A3S stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+73.7%
S&P 500 1Y: n/a
3Y total return
+33.1%
S&P 500 3Y: n/a
5Y total return
-94.1%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns LON/0A3S?

Insider, institutional, and short-interest positioning.

Institutional ownership
+58.0%
Share of float held by funds and institutions
Insider ownership
+0.8%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
10.3 days to cover
Y/Y dilution
+0.6%
Negative means the company is buying back shares.
Technical

LON/0A3S momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
71.3
Above 70: short-term overbought
Price vs 200-day MA
+26.1%
50/200-day relationship not available
Beta (5Y)
2.65
More volatile than the market
Sharpe ratio
1.03
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About LON/0A3S

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0A3S stock rating?

lon/0A3S is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0A3S analysis?

The full report lives at /stocks/lon/0A3S/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0A3S?

The latest report frames lon/0A3S around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0A3S page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.